Articles On Botanix Pharmaceuticals (ASX:BOT)

At the start of every trading day, it can be useful to know which stocks are humming out of the gate. Often, the moves are part of the usual market ructions in small caps, but sometimes a big announcement can cause a stock to rocket higher...

Medical dermatology company Botanix Pharmaceuticals (ASX:BOT) has updated investors on the findings of the BTX 1801 antimicrobial study.

Shares in grow-your-own-bone biotech Orthocell (ASX:OCC) are up after it proved, once again, that we live in science fiction times. Today the company said all 10 patients in a dental bone regeneration study had successfully grown enough new...

The market has continued its charge on Wednesday and is trading notably higher this morning. Two companies that are certainly on a high right now are the cannabis companies listed below. Here’s why they are smoking the market today: The Bot...

New results from a “world-first” study by Botanix Pharmaceuticals (ASX: BOT) has identified significant anti-inflammatory and immune modulating effects from using cannabidiol (CBD) to treat skin diseases such as psoriasis. The medical derma...

Two stocks BOT and PM1 are on trading halts, pending their upcoming announcements on ASX. Let us have an overview of the recent developments and the performance of the stocks for these companies. Botanix Pharmaceuticals Limited Strong Devel...

Honey containing THC *might* be able to be exported and imported. The UK is the Next Big Thing in pot, Brexit or no. And 2020 is starting to look like a very hard deadline for a series of big events. There are 30 companies doing, or saying...

Honey containing THC *might* be able to be exported and imported. The UK is the Next Big Thing in pot, Brexit or no. And 2020 is starting to look like a very hard deadline for a series of big events. There are 30 companies doing, or saying...